menu
    • menu

    Company profile for Portage Biotech

    NEW Drugs in Dev: 6
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Despite advances in the immuno-oncology field, 70-80% of patients do not respond or have a limited response to existing therapies, such as checkpoint inhibitors. Portage Biotech aims to change this with a unique approach that drives the development of first-in-class immuno-oncology therapies for patients with cancer. We know quality science and leverage our team’s deep knowledge to create a viable product development strat...
    Despite advances in the immuno-oncology field, 70-80% of patients do not respond or have a limited response to existing therapies, such as checkpoint inhibitors. Portage Biotech aims to change this with a unique approach that drives the development of first-in-class immuno-oncology therapies for patients with cancer. We know quality science and leverage our team’s deep knowledge to create a viable product development strategy that supports commercial potential and company growth. We execute the development process and create strategies to guide novel immuno-oncology assets and asset combinations from bench through human proof of concept.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Portage Biotechunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Clarence Thomas Building, (302) 219-5556 P.O. Box 4649, Road Town, Tortola, Br...
    Telephone
    Telephone
    416.929.1806
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.portagebiotech.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alphaton Capital Closes $71M Financing, Completes Ton Token
    Alphaton Capital Closes $71M Financing, Completes Ton Token

    25 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/25/3156641/0/en/AlphaTON-Capital-Corp-Successfully-Closes-71-million-Financing-and-Completes-Initial-TON-Token-Acquisition.html

    GLOBENEWSWIRE
    25 Sep 2025
    Share Share
    Portage Biotech Reports Fiscal Year Results Ending March 31, 2025
    Portage Biotech Reports Fiscal Year Results Ending March 31, 2025

    25 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/25/3121999/0/en/Portage-Biotech-Reports-Results-for-Fiscal-Year-Ended-March-31-2025.html

    GLOBENEWSWIRE
    25 Jul 2025
    Share Share
    Portage Biotech Regains Nasdaq Compliance
    Portage Biotech Regains Nasdaq Compliance

    25 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/25/3104952/0/en/Portage-Biotech-Regains-Full-Compliance-with-Nasdaq-Continued-Listing-Requirements.html

    GLOBENEWSWIRE
    25 Jun 2025
    Share Share
    Portage Biotech and Compedica Stock-for-Stock Exchange
    Portage Biotech and Compedica Stock-for-Stock Exchange

    09 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/09/3095684/0/en/Portage-Biotech-and-Compedica-Stock-for-Stock-Exchange.html

    GLOBENEWSWIRE
    09 Jun 2025
    Share Share
    Portage Confirms Preclinical PORT-7 Results in Mesothelioma
    Portage Confirms Preclinical PORT-7 Results in Mesothelioma

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3068995/0/en/Portage-Biotech-Reports-Confirmatory-Preclinical-Results-in-Mesothelioma-Supporting-First-In-Human-Trial-of-PORT-7.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share
    Portage Bio Reports Promising Preclinical Results In Mesothelioma
    Portage Bio Reports Promising Preclinical Results In Mesothelioma

    27 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/27/3051025/0/en/Portage-Biotech-Reports-Promising-Preclinical-Results-in-Mesothelioma-Supporting-First-In-Human-Trial-of-PORT-7.html

    GLOBENEWSWIRE
    27 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search